Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA243694
Max Phase: Preclinical
Molecular Formula: C27H32FN3O3
Molecular Weight: 465.57
Molecule Type: Small molecule
Associated Items:
ID: ALA243694
Max Phase: Preclinical
Molecular Formula: C27H32FN3O3
Molecular Weight: 465.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1
Standard InChI: InChI=1S/C27H32FN3O3/c1-18(2)34-24-9-4-3-8-23(24)30-16-14-29(15-17-30)19-10-12-20(13-11-19)31-26(32)21-6-5-7-22(28)25(21)27(31)33/h3-9,18-20H,10-17H2,1-2H3
Standard InChI Key: DXHONOPMEUDNFH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 465.57 | Molecular Weight (Monoisotopic): 465.2428 | AlogP: 4.34 | #Rotatable Bonds: 5 |
Polar Surface Area: 53.09 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.34 | CX LogP: 4.54 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 34 | QED Weighted: 0.62 | Np Likeness Score: -1.12 |
1. Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA.. (2007) 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands., 17 (6): [PMID:17254786] [10.1016/j.bmcl.2006.12.111] |
2. Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA.. (2007) 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands., 17 (6): [PMID:17254786] [10.1016/j.bmcl.2006.12.111] |
Source(1):